Similar Papers

Paper Title
Journal
Date
Author
Topotecan and Paclitaxel in Previously Treated Patients with Relapsed Small Cell Lung Cancer: Phase II Trial of the North Central Cancer Treatment Group
Grace K Dy ... Henry Tazelaar
Journal of Thoracic Oncology | VOL. 1
Grace K Dy, et. al.Grace K Dy ... Henry Tazelaar
01 Mar 2006
Comparison of Carboplatin With Cisplatin in Small Cell Lung Cancer in US Veterans
Ibrahim Azar ... Omid Yazdanpanah
JAMA Network Open | VOL. 5
Ibrahim Azar, et. al.Ibrahim Azar ... Omid Yazdanpanah
20 Oct 2022
Comparison of efficacy and safety between PD-1 inhibitors and PD-L1 inhibitors plus platinum-etoposide as first-line treatment for extensive-stage small-cell lung cancer: a multicenter, real-world analysis
Yanrong Wang ... Guanghai Dai
BMC Cancer | VOL. 23
Yanrong Wang, et. al.Yanrong Wang ... Guanghai Dai
06 Dec 2023
A retrospective study of first line atezolizumab-carboplatin-etoposide in extensive-stage small cell lung cancer: Real world data from a Spanish tertiary center.
Failah Mohamed Lamin ... María Jesús Salas
Journal of Clinical Oncology | VOL. 42
Failah Mohamed Lamin, et. al.Failah Mohamed Lamin ... María Jesús Salas
01 Jun 2024
View more papers

More From: Proceedings of Anticancer Research

Paper Title
Journal
Date
Author
Application Value of Artificial Intelligence-Assisted Diagnostic Systems in CT Diagnosis of Pulmonary Nodules
Yang Xue ... Bing Han
Proceedings of Anticancer Research | VOL. -
Yang Xue, et. al.Yang Xue ... Bing Han
16 Jan 2025
-
-
Proceedings of Anticancer Research | VOL. -
--
16 Jan 2025
Observation on the Therapeutic Effect of Hypotonic Hyperthermic Intraperitoneal Chemotherapy in the Treatment of Advanced Gastric Cancer and Ovarian Cancer Accompanied by Ascites
Wei Mi ... Yang Yu
Proceedings of Anticancer Research | VOL. 8
Wei Mi, et. al.Wei Mi ... Yang Yu
27 Nov 2024
Application Value of 3D Printing Technology in Breast Cancer Treatment
Zhanyi Sun
Proceedings of Anticancer Research | VOL. 8
Zhanyi SunZhanyi Sun
27 Nov 2024
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.